Westwater Resources Inc
Change company Symbol lookup
Select an option...
WWR Westwater Resources Inc
AGNPF Algernon Pharmaceuticals Inc
VNTR Venator Materials PLC
DVAX Dynavax Technologies Corp
GE General Electric Co
GTPBU Gores Technology Partners II Inc
IRBT iRobot Corp
NRG NRG Energy Inc
FRLAU Fortune Rise Acquisition Corp
BTBT Bit Digital Inc
Go

Industrials : Electrical Equipment | Small Cap Value
Company profile

Westwater Resources Inc. is a diversified energy materials developer. The Company holds battery-graphite development properties in Alabama. The Company’s projects include Coosa Graphite Project, Bama Mine Project, COOSA Graphite-Vanadium Project. The Company’s COOSA Graphite Project comprises of 42,000 acres (more than 65 square miles) and is a graphite project. It is located in western Coosa County, east-central Alabama, the United States of America (USA). The Bama Mine Project is located in Alabama Graphite Belt and comprises of 1,300 acres of land. The vanadium mineralization at the Coosa project occurs principally as the mineral roscoelite, a medium to dark green mica mineral that has been a global source for vanadium.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.13
Day's Change
-0.06 (-5.04%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.22
Day's Low
1.13
Volume
(Light)
Volume:
282,783

10-day average volume:
361,457
282,783

Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022

8:30 am ET August 4, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:BFRI ),(NASDAQ:BFRIW), EQNX::TICKER_END Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2022 before the opening of the U.S. financial markets on Friday, August 12, 2022. The Company will hold a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions.

Conference Call and Webcast Information

Event:           Biofrontera Inc. Second Quarter 2022 Financial Results and Business Update Conference Call
Date:            Friday, August 12, 2022
Time:            11:00 a.m. Eastern time
Conference call: 1-877-877-1275 (U.S.)
                 1-412-858-5202 (international)
Webcast:         Live and 90-day replay webcast are available here and at www.investors.biofrontera-us.com.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts

Biofrontera Inc.

Anke zur Muhlen

+1 781 486 1539

us-ir@biofrontera.com

LHA Investor Relations

Tirth T. Patel

+1 212 201 6614

tpatel@lhai.com

###

https://ml.globenewswire.com/media/abfee277-1c7d-451f-a2a7-b7cf09ebd055/small/logo-png.png

https://ml.globenewswire.com/media/abfee277-1c7d-451f-a2a7-b7cf09ebd055/small/logo-png.png

comtex tracking

COMTEX_411576290/2010/2022-08-04T08:30:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.